the invention generally relates to topical and aerosolized compositions for inducing vasoconstriction with low incidence of rebound hyperemia

brevets / patents
- wipo.int

Discussion of the specific advantages: its specific mode of action as a non-selective beta-adrenergic receptor blocking agent, causes vasoconstriction, which in turns leads to decrease of the aqueous humour.

Discussion of the specific advantages: its specific mode of action as a non-selective beta-adrenergic receptor blocking agent, causes vasoconstriction, which in turns leads to decrease of the aqueous humour.